Amid growing global concerns over infectious disease outbreaks like Mpox, the urgency for cutting-edge diagnostic and therapeutic innovations has never been greater. Join us at PMWC 2025, where world-renowned experts will share the latest advancements in precision diagnostics and public health solutions.
We are honored to present Dr. Julie Louise Gerberding as the Pioneer Honoree at the PMWC 2025 Silicon Valley – Feb 5-7 Award Ceremony. Dr. Gerberding, a leading figure in public-private partnerships, emphasizes the critical importance of collaboration: “Many of today’s medical challenges are so complex that no single institution or organization can solve them alone. Team Science is essential.” Her insights will set the tone for exploring innovative diagnostic and therapeutic strategies.
The session “Harnessing Emerging Diagnostic Technologies in Primary and Critical Care” chaired by Mylynda Massart, UPMC, will feature discussions with experts like Christopher Woods (Duke), Helen Chu (University of Washington), Yvonne (Bonnie) Maldonado (Stanford), and Rose Lee (NIH). This panel will examine cutting-edge diagnostic tools and their applications in managing infectious diseases.
We’re also thrilled to highlight Brad Spellberg‘s presentation on the AMMA vaccine, which leverages Trained Immunity to protect against multiple pathogens and address healthcare-associated infections. This significant advancement showcases a forward-thinking approach to infectious disease prevention, which aligns with the broader theme of therapeutic innovations.
The session, “Innovative Therapeutics and Host-Pathogen Interactions in Infectious Disease Management,” will delve into groundbreaking treatments for global health threats. This panel features Victor Nizet (UCSD), Brad Spellberg (LA General Medical Center), Nevan Krogan (UCSF), and Margaret Riley (University of Massachusetts), who will provide insights into the evolving landscape of infectious disease management and therapeutic development.
Furthermore, the session “Metagenomics and Partnerships: Monitoring Infectious Disease Threats” led by Duncan MacCannell will discuss how metagenomic technologies are transforming disease surveillance. MacCannell will be joined by Adi V. Gundlapalli (CDC) and Mindy Nye (LabCorp) to discuss the essential role of infrastructure in detecting emerging pathogens.
Charles Chiu will chair a session on “New Viral and Microbiome Associations with Cancer“, alongside Nancy Joseph (UCSF) and Melody Smith (Stanford), shedding light on novel viral associations in oncology.
Finally, don’t miss Dr. Julie Louise Gerberding’s keynote “From Crisis to Cure: Navigating Public Health Challenges in the Era of Precision Diagnostics,” where she will provide invaluable insights on accelerating innovation through strategic collaborations.
We look forward to your participation in this educational conference (12 TRACK PROGRAM – Register), where groundbreaking solutions for infectious diseases will be explored and discussed by some of the field’s top experts.
Let me know if you have any questions.
Tal Behar
President & Co-founder, PMWC
PMWC 2025 Silicon Valley – February 5-7, 2025
